Avecho Biotechnology Ltd (AVE) — Capital Reinvestment Ratio
Latest as of December 2019:
0.00x
Avecho Biotechnology Ltd (AVE) has a Capital Reinvestment Ratio of 0.00x as of December 2019, meaning it reinvests 0% of its operating cash flow (AU$1.19 Million) in capital expenditures (AU$5.15K). See Avecho Biotechnology Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
AU$1.19 Million
AUD
Capital Expenditures
AU$5.15K
AUD
Data as of
Dec 2019
Most recent filing
Avecho Biotechnology Ltd Capital Reinvestment Ratio (2019–2019)
This chart tracks Avecho Biotechnology Ltd's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Avecho Biotechnology Ltd (2019–2019)
Year-by-year Capital Reinvestment Ratio for Avecho Biotechnology Ltd from 2019 to 2019. For live market cap and broader valuation context, see AVE market cap overview.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.00x | AU$1.19 Million | AU$5.15K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow